Literature DB >> 33804165

The Role of Polycomb Group Protein BMI1 in DNA Repair and Genomic Stability.

Amira Fitieh1,2, Andrew J Locke2, Mobina Motamedi2, Ismail Hassan Ismail1,2.   

Abstract

The polycomb group (PcG) proteins are a class of transcriptional repressors that mediate gene silencing through histone post-translational modifications. They are involved in the maintenance of stem cell self-renewal and proliferation, processes that are often dysregulated in cancer. Apart from their canonical functions in epigenetic gene silencing, several studies have uncovered a function for PcG proteins in DNA damage signaling and repair. In particular, members of the poly-comb group complexes (PRC) 1 and 2 have been shown to recruit to sites of DNA damage and mediate DNA double-strand break repair. Here, we review current understanding of the PRCs and their roles in cancer development. We then focus on the PRC1 member BMI1, discussing the current state of knowledge of its role in DNA repair and genome integrity, and outline how it can be targeted pharmacologically.

Entities:  

Keywords:  BMI1; DNA repair; EZH2; PRC1; PRC2; PcG; chromatin; genome instability; histone modification; polycomb; transcription silencing

Mesh:

Substances:

Year:  2021        PMID: 33804165      PMCID: PMC7998361          DOI: 10.3390/ijms22062976

Source DB:  PubMed          Journal:  Int J Mol Sci        ISSN: 1422-0067            Impact factor:   5.923


  247 in total

1.  βTrCP regulates BMI1 protein turnover via ubiquitination and degradation.

Authors:  Anagh A Sahasrabuddhe; Manjari Dimri; Prashant V Bommi; Goberdhan P Dimri
Journal:  Cell Cycle       Date:  2011-04-15       Impact factor: 4.534

2.  DNAPKcs-dependent arrest of RNA polymerase II transcription in the presence of DNA breaks.

Authors:  Tibor Pankotai; Céline Bonhomme; David Chen; Evi Soutoglou
Journal:  Nat Struct Mol Biol       Date:  2012-02-12       Impact factor: 15.369

3.  Dysregulated expression of stem cell factor Bmi1 in precancerous lesions of the gastrointestinal tract.

Authors:  Keisuke Tateishi; Miki Ohta; Fumihiko Kanai; Bayasi Guleng; Yasuo Tanaka; Yoshinari Asaoka; Motohisa Tada; Motoko Seto; Amarsanaa Jazag; Lin Lianjie; Makoto Okamoto; Hiroyuki Isayama; Minoru Tada; Haruhiko Yoshida; Takao Kawabe; Masao Omata
Journal:  Clin Cancer Res       Date:  2006-12-01       Impact factor: 12.531

4.  Transcriptional elongation factor ENL phosphorylated by ATM recruits polycomb and switches off transcription for DSB repair.

Authors:  Ayako Ui; Yuko Nagaura; Akira Yasui
Journal:  Mol Cell       Date:  2015-04-23       Impact factor: 17.970

5.  RYBP, a new repressor protein that interacts with components of the mammalian Polycomb complex, and with the transcription factor YY1.

Authors:  E García; C Marcos-Gutiérrez; M del Mar Lorente; J C Moreno; M Vidal
Journal:  EMBO J       Date:  1999-06-15       Impact factor: 11.598

6.  BMI-1 gene amplification and overexpression in hematological malignancies occur mainly in mantle cell lymphomas.

Authors:  S Beà; F Tort; M Pinyol; X Puig; L Hernández; S Hernández; P L Fernandez; M van Lohuizen; D Colomer; E Campo
Journal:  Cancer Res       Date:  2001-03-15       Impact factor: 12.701

7.  Sequence similarity between the mammalian bmi-1 proto-oncogene and the Drosophila regulatory genes Psc and Su(z)2.

Authors:  M van Lohuizen; M Frasch; E Wientjens; A Berns
Journal:  Nature       Date:  1991-09-26       Impact factor: 49.962

Review 8.  Targeting polo-like kinase 1 for cancer therapy.

Authors:  Klaus Strebhardt; Axel Ullrich
Journal:  Nat Rev Cancer       Date:  2006-04       Impact factor: 60.716

9.  Non-Canonical EZH2 Transcriptionally Activates RelB in Triple Negative Breast Cancer.

Authors:  Cortney L Lawrence; Albert S Baldwin
Journal:  PLoS One       Date:  2016-10-20       Impact factor: 3.240

10.  The E3 ubiquitin-ligase Bmi1/Ring1A controls the proteasomal degradation of Top2alpha cleavage complex - a potentially new drug target.

Authors:  Iris Alchanati; Carmit Teicher; Galit Cohen; Vivian Shemesh; Haim M Barr; Philippe Nakache; Danny Ben-Avraham; Anna Idelevich; Itzchak Angel; Nurit Livnah; Shmuel Tuvia; Yuval Reiss; Daniel Taglicht; Omri Erez
Journal:  PLoS One       Date:  2009-12-01       Impact factor: 3.240

View more
  6 in total

1.  MicroRNA-20a Suppresses Tumor Proliferation and Metastasis in Hepatocellular Carcinoma by Directly Targeting EZH1.

Authors:  Qianqian Zhang; Xiaohong Deng; Xiuxin Tang; Ying You; Meihua Mei; Danping Liu; Lian Gui; Yan Cai; Xiaoping Xin; Xiaoshun He; Junqi Huang
Journal:  Front Oncol       Date:  2021-12-16       Impact factor: 6.244

Review 2.  3D chromatin architecture and transcription regulation in cancer.

Authors:  Siwei Deng; Yuliang Feng; Siim Pauklin
Journal:  J Hematol Oncol       Date:  2022-05-04       Impact factor: 23.168

Review 3.  Protein kinase CK2 - diverse roles in cancer cell biology and therapeutic promise.

Authors:  Janeen H Trembley; Betsy T Kren; Muhammad Afzal; George A Scaria; Mark A Klein; Khalil Ahmed
Journal:  Mol Cell Biochem       Date:  2022-09-17       Impact factor: 3.842

4.  The Systematic Analyses of RING Finger Gene Signature for Predicting the Prognosis of Patients with Hepatocellular Carcinoma.

Authors:  Chunfeng Zhang; Yang Yang; Kun Wang; Muhua Chen; Min Lu; Chenyu Hu; Xiaojuan Du; Baocai Xing; Xiaofeng Liu
Journal:  J Oncol       Date:  2022-09-26       Impact factor: 4.501

5.  Quercetin Prevents Radiation-Induced Oral Mucositis by Upregulating BMI-1.

Authors:  Jing Zhang; Yiyang Hong; Zhenyu Liuyang; Haozhe Li; Zhongyang Jiang; Jingjing Tao; Hai Liu; Anyong Xie; Yili Feng; Xingjian Dong; Yihong Wang; Qinghua Dong; Guanyu Wang
Journal:  Oxid Med Cell Longev       Date:  2021-11-27       Impact factor: 6.543

Review 6.  The Sound of Silence: How Silenced Chromatin Orchestrates the Repair of Double-Strand Breaks.

Authors:  Apfrida Kendek; Marieke R Wensveen; Aniek Janssen
Journal:  Genes (Basel)       Date:  2021-09-15       Impact factor: 4.096

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.